Aignostics
PrivateLast Round
Series B
Oct 29, 2024
Total Funding Raised
$53.9M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Aignostics is a healthcare technology company that provides an artificial intelligence-driven image analysis platform to enhance precision medicine by providing explainable diagnostic insights for cancer and complex disease diagnosis and treatment.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Usage-Based SaaS
AI Layer
Foundation
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Aignostics Comparables
Compare Aignostics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Nucleai | 87% | |
| AIRA Matrix | 83% | |
| Tempus | 83% |
Aignostics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Oct 29, 2024 | ||||
| Series A | Sep 15, 2022 | ||||
| Seed | Aug 28, 2020 | ||||
| Accelerator | Jan 1, 2018 |
Aignostics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| State of Berlin | Series B, Series A, Seed |
| IBB Ventures | Series B, Series A, Seed |
| Athos KG | Series B |
| Ascenion | Series B, Series A |
| Boehringer Ingelheim Venture Fund | Series B, Series A, Seed |
| Wellington Partners | Series B, Series A |
| Future Capital AG | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 27, 2026
Monthly visitors grew 108% MoM, reaching 12.5K.
- Jun 5, 2026
Company is a spin-off from the Charité university hospital.
Recent news
Latest coverage and updates
- integrates_withSep 12, 2026
Aignostics integrated with Techcyte on Sep 12th '26.
- launchesSep 12, 2026
Aignostics launched PathoSearch on Sep 12th '26.
Aignostics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Aignostics's valuation, stock price, and market status.
Is Aignostics a public or private company?
Aignostics is a private company.
What is the current stock price of Aignostics?
Aignostics is a private company with no public stock price. No recent secondary market data is available.
How much is Aignostics worth (valuation)?
Valuation information for Aignostics is not publicly available.
Can I buy Aignostics stock?
Aignostics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Aignostics's last funding round?
Aignostics's most recent funding round was Series B on October 29, 2024.
Who are the main investors in Aignostics?
Key investors in Aignostics include Athos KG, Boehringer Ingelheim Venture Fund, Wellington Partners.
Will Aignostics IPO soon?
No public IPO plans have been announced for Aignostics.
How can I track Aignostics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Aignostics's secondary market activity and sign up for updates.